Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Whitty

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
BMJ Open|April 15, 2017
Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trialHolly Foot, Christopher Freeman, Karla Hemming, et al.
BMC Pediatrics|November 18, 2015
Early high flow nasal cannula therapy in bronchiolitis, a prospective randomised control trial (protocol): A Paediatric Acute Respiratory Intervention Study (PARIS)Donna Franklin, Stuart Dalziel, Luregn J Schlapbach, et al.
Journal of Health Organization and Management|July 30, 2016
Public participation in decision-making on the coverage of new antivirals for hepatitis CKatharina Kieslich, Jeonghoon Ahn, Gabriele Badano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 8, 2025
Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice ExperimentHui Lu, Travis Gould, Carmine Colavecchia, et al.
Journal of Health Organization and Management|July 30, 2016
Patterns of public participationJean Slutsky, Emma Tumilty, Catherine Max, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
The Lancet. Digital Health|December 18, 2020
Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trialMonika Janda, Caitlin Horsham, Dimitrios Vagenas, et al.
The European Respiratory Journal|November 9, 2019
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx TrialJennifer A Whitty, Jenny Rankin, Dina Visca, et al.
Trials|April 30, 2017
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialDina Visca, Vicky Tsipouri, Letizia Mori, et al.
Journal of the Royal Society of Medicine|April 3, 2019
National Institute for Health and Care Excellence, social values and healthcare priority settingPeter Littlejohns, Kalipso Chalkidou, Anthony J Culyer, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
BMJ Open|April 15, 2017
Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trialHolly Foot, Christopher Freeman, Karla Hemming, et al.
BMC Pediatrics|November 18, 2015
Early high flow nasal cannula therapy in bronchiolitis, a prospective randomised control trial (protocol): A Paediatric Acute Respiratory Intervention Study (PARIS)Donna Franklin, Stuart Dalziel, Luregn J Schlapbach, et al.
Journal of Health Organization and Management|July 30, 2016
Public participation in decision-making on the coverage of new antivirals for hepatitis CKatharina Kieslich, Jeonghoon Ahn, Gabriele Badano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 8, 2025
Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice ExperimentHui Lu, Travis Gould, Carmine Colavecchia, et al.
Journal of Health Organization and Management|July 30, 2016
Patterns of public participationJean Slutsky, Emma Tumilty, Catherine Max, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
The Lancet. Digital Health|December 18, 2020
Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trialMonika Janda, Caitlin Horsham, Dimitrios Vagenas, et al.
The European Respiratory Journal|November 9, 2019
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx TrialJennifer A Whitty, Jenny Rankin, Dina Visca, et al.
Trials|April 30, 2017
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialDina Visca, Vicky Tsipouri, Letizia Mori, et al.
Journal of the Royal Society of Medicine|April 3, 2019
National Institute for Health and Care Excellence, social values and healthcare priority settingPeter Littlejohns, Kalipso Chalkidou, Anthony J Culyer, et al.
Pageof 22